Anti-Rat C5L2 Polyclonal Antibody-0.5 mg (CAT#: CB-P416-AB) Datasheet

Product Type
Antibody
Description
The polyclonal antibody reacts with rat C5L2. The orphan receptor C5L2 is a seven transmembrane receptor with 40% amino acid sequence identity with the C5a receptor CD88. It has been found to be expressed on granulocytes and immature dendritic cells. Compared with CD88, C5L2 is uncoupled from G protein due to the substitution of leucine amino acids for arginine in the so-called DRY region at the end of the third intracellular transmembrane domain. After C5a is bound, C5L2 does not seem to induce classical signaling nor biological response. When C5L2 is transfected into several cell types, C5a cannot induce chemotaxis, degranulation, or intercellular calcium mobilization. C5L2 has high affinity for C5a and its metabolite C5adesArg, but low affinity for C3a and C3adesArg, indicating that this receptor is a scavenger of complement fragments and participates in defense against harmful side effects of complement activation. It is known that C5L2 expression on human neutrophils is reduced in sepsis; since sepsis survivors tend to have higher C5L2 levels, loss of expression may be a prognostic indicator in this case.
Disease
Pulmonology
Size
100 µg
Species
Rat
Host
Rabbit
Clonality
Polyclonal
Isotype
Rabbit IgG
Buffer
PBS, containing 0.1% bovine serum albumin.
Application
Flow cytometry, Functional studies
Application Notes
For flow cytometry, the use of diluent depends on the detection system used. It is recommended that users test reagents and determine their own optimal dilution. The typical initial working dilution is 1:50.
Storage Instructions
Product should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year.
Target
C5L2
Alternative Names
C5AR2; C5L2; GPF77; GPR77; complement component 5a receptor 2

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK